Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas

SIMPLE SUMMARY: Targeted therapies have revolutionized the management of hematological malignancies and solid organ cancers. These new treatments present numerous infectious complications. We aim to present the main infectious complications related to immune checkpoint inhibitors, Bruton’s tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilmis, Benoît, Kherabi, Yousra, Huriez, Pauline, Zahar, Jean-Ralph, Mokart, Djamel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093532/
https://www.ncbi.nlm.nih.gov/pubmed/37046650
http://dx.doi.org/10.3390/cancers15071989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093532/
https://www.ncbi.nlm.nih.gov/pubmed/37046650
http://dx.doi.org/10.3390/cancers15071989

Ejemplares similares